Goodwin partner Alexander Varond was named a 2021 D.C. Rising Star by The National Law Journal. The Rising Star awards recognize the 40 most promising lawyers age 40 and younger in the Washington, D.C. area who have become influential in their areas of practice.
A partner in Goodwin’s Technology & Life Sciences group and co-chair of the firm’s FDA Litigation practice, Varond is knowledgeable across a wide range of FDA regulatory matters with extensive experience in medical device and drug development, patent and exclusivity issues, as well as regulatory strategy. He also counsels clients on advertising and promotional issues, corporate transactions, and defends companies during civil and criminal investigations on matters such as off-label promotion and GMPs. Varond’s key focuses include orphan drug development, accelerated approval and patient advocacy.
In addition to his practice, Varond is a highly sought-after speaker, educator and writer. He has also co-taught a course on medical device and drug regulatory law for the Department of Biomedical Engineering at The George Washington University and guest lecturers both in the United States and internationally.
In the community, Varond leverages his passion and expertise in rare disease advocacy and serves as a board member of the NAA10 Foundation, a patient advocacy group dedicated to supporting families with NAA10, an ultra-rare, life-threatening childhood neurodevelopmental condition. He is also an active member of several industry groups and the Asian Pacific American Bar Association. Additionally, Varond dedicates himself to a variety of pro bono projects, including the New England Innocence Project and VoteRiders.
Varond and the other winners will be honored at The National Law Journal’s awards reception in Washington, D.C. on October 20.